BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16081961)

  • 1. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.
    Hatakeyama S; Sakai-Tagawa Y; Kiso M; Goto H; Kawakami C; Mitamura K; Sugaya N; Suzuki Y; Kawaoka Y
    J Clin Microbiol; 2005 Aug; 43(8):4139-46. PubMed ID: 16081961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
    Hurt AC; Barr IG; Hartel G; Hampson AW
    Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.
    Gubareva LV; Kaiser L; Matrosovich MN; Soo-Hoo Y; Hayden FG
    J Infect Dis; 2001 Feb; 183(4):523-31. PubMed ID: 11170976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.
    Matrosovich M; Matrosovich T; Carr J; Roberts NA; Klenk HD
    J Virol; 2003 Aug; 77(15):8418-25. PubMed ID: 12857911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
    Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac.
    Kato D; Kurebayashi Y; Takahashi T; Otsubo T; Otake H; Yamazaki M; Tamoto C; Minami A; Ikeda K; Suzuki T
    PLoS One; 2018; 13(7):e0200761. PubMed ID: 30001430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
    Mungall BA; Xu X; Klimov A
    Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDCK-B4GalNT2 cells disclose a α2,3-sialic acid requirement for the 2009 pandemic H1N1 A/California/04/2009 and NA aid entry of A/WSN/33.
    Wong HH; Fung K; Nicholls JM
    Emerg Microbes Infect; 2019; 8(1):1428-1437. PubMed ID: 31560252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding.
    Mohr PG; Deng YM; McKimm-Breschkin JL
    Virol J; 2015 Apr; 12():67. PubMed ID: 25896455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
    Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
    Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
    Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
    J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
    Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
    J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
    Abed Y; Bourgault AM; Fenton RJ; Morley PJ; Gower D; Owens IJ; Tisdale M; Boivin G
    J Infect Dis; 2002 Oct; 186(8):1074-80. PubMed ID: 12355356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.
    Rameix-Welti MA; Agou F; Buchy P; Mardy S; Aubin JT; Véron M; van der Werf S; Naffakh N
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3809-15. PubMed ID: 16940075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.